As the pandemic begins to recede in some countries and global businesses take steps toward recovery, what will reemerging supply chains look like?

You might say the coronavirus pandemic is bringing about a seismic shift in attitudes toward supply-chain risk.

An ethical supply chain is only as good as its partners' ability to collaborate — and anticipate future challenges.

Does the vision of a “new normal” on the factory floor exclude the presence of people at all?

The coronavirus pandemic has revealed the need for breaking the United States’ dependence on manufacturing in China and other countries.

Claudia Lewis, partner with Venable LLP, describes how the U.S. Food and Drug Administration is revising its policies, practices and regulations in response to the coronavirus pandemic.